The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Oncolix, Inc. - Clinical-stage Biotechnology Company Developing Prolanta™ for the Treatment of Ovarian, Uterine, Breast and Other Cancers

SNNLive spoke with Michael Redman, President and CEO of Oncolix, Inc., (OTCQB: ONCX) at the LD Micro Invitational 2018 in Bel Air, CA.

Share With

Tuesday, August 07, 2018

   

© 2018 Stock News Now